Sinovac Biotech Meets Nasdaq Listing Standards
Sinovac Biotech Ltd. has announced its successful return to full compliance with the Nasdaq Global Market's listing requirements. This indicates the company has addressed previous issues that might have jeopardized its stock exchange status.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.